Excited about this new @JNCI_Now Commentary article by my colleague @LynnMatrisian @PanCAN and collaborators, describing "heuriskance," a novel strategy for identifying people at high risk for having a disease such as #pancreaticcancer.

In @JNCI_Now we introduce a novel approach for systematic earlier detection of sporadic #PancreaticCancer: HEURISKANCE This is distinct from longitudinal surveillance in high risk individuals & represents opportunistic early detection of a lethal cancer. https://t.co/qQsuxfxUj7

For people with #pancreaticcancer and their loved-ones, PanCAN Patient Services serves as a vital resource during what can be a complicated and difficult time. 💜 Our team of expert Case Managers walk with patients through challenges and decision points, providing information and

I’ll be sharing my key takeaways later this month in my @PanCAN Research Spotlight blog — for now, thank you to everyone who made this gathering so meaningful and inspiring!

What an incredible time last week in Boston with @PanCAN’s Community for Progress at our Scientific Summit! It was inspiring to see researchers, patient advocates, and partners come together to share advances in #pancreaticcancer research and care.

Did you know that mutations in the “breast cancer genes,” BRCA1 and BRCA2, increase a person’s lifetime risk of developing breast, ovarian AND other cancer types, including pancreatic? 🧬 This can affect both men and women. In conjunction with 🩷🎗️ Breast Cancer Awareness Month,

Kudos to @PanCAN for creating the SPARK data platform containing vast troves of clinical, imaging, laboratory & molecular data from Precision Promise and Know Your Tumor. Fabulous resource for #PancreaticCancer researchers in both academia and industry. @sdosssdoss

Delighted to be at the @PanCAN summit in Boston and hear all the exciting advances in #PancreaticCancer from all our grantees. PanCAN is a wonderful organization that has helped bring many early career investigators into the field. Perfect prelude to the start of #AACRPan25 today

Thank you @PanCAN for the opportunity to speak at the Scientific Summit! Grateful to share our work using the #SPARK platform to study KRAS in #pancreaticcancer, accelerating discovery & collaboration. Exciting new data coming soon! 🔬 #PancreaticCancer #KRAS

Always inspiring to hear from @JulieFleshman and @aberkenblit at the annual @PanCAN Scientific Summit. Excited for a day of science working to improve outcomes for everyone affected by #pancreaticcancer 💜

This weekend in Boston, PanCAN brought together our Community for Progress at our annual Scientific Summit — a gathering of researchers, patient advocates, industry partners, PanCAN grantees, volunteers and donors dedicated to advancing #pancreaticcancer research and care. 🔬🧬🧪

In my Research Spotlight this month, I spoke with @PanCAN’s Chief Business Officer, Sudheer Doss, PhD, about how AI and SPARK are working together to advance #pancreaticcancer research.

At @PanCAN, we are leveraging de-identified patient health data within PanCAN’s SPARK, a data integration and analytics platform, to accelerate discoveries through both academic and commercial partnerships.

🧵 Artificial intelligence (AI) is transforming #biomedical research, from biomarker discovery to clinical trial design.

In this month’s Research Spotlight, Dr. @ABerkenblit, PanCAN’s Chief Scientific and Medical Officer, and Sudheer Doss, PhD, PanCAN’s Chief Business Officer, discuss how artificial intelligence (AI) and PanCAN’s SPARK data platform are accelerating discoveries in

Pancreatic cancer researcher and professor Luisa Escobar-Hoyos, MSc, PhD, saw her work hit too close to home when her mother Luz, also a cancer researcher and professor, was diagnosed with one of the world’s toughest cancers. 💜 https://t.co/aoROJDqEI9 So, when Dr.

This partnership with @Smart_Patients extends @PanCAN’s Patient Services support by offering a place where patients and caregivers can also connect with peers who understand their experience. Together, we’re ensuring no one has to face this disease alone.

Pancreatic cancer remains one of the deadliest cancers because it is often detected at an advanced stage when treatment options are limited. PanCAN launched its Early Detection Initiative (EDI) to investigate whether a rise in blood sugar, in combination with other clinical

💜 8,800+ voices are helping science find new early warning signs of pancreatic cancer. It all starts with insulin, weight—and knowing what to look for. @PanCAN's ENDPAC is on it.

At @PanCAN, we continue to emphasize the importance of clinical trial participation at every treatment decision point. Patients and families seeking guidance can connect with PanCAN Patient Services for a personalized clinical trial search.